跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CLARYTAS 250 TABLET 250 mg - HSA Drug Approval Details
Approvals
/
HSA
/
CLARYTAS 250 TABLET 250 mg
Approved
THERAPEUTIC
CLARYTAS 250 TABLET 250 mg
INTAS PHARMACEUTICALS LTDIntas Pharmaceuticals Ltd.
🇸🇬 Health Sciences Authority
Approval Date
Dec 6, 2001
Approval ID
bb3661aaec8449cf
Company
INTAS PHARMACEUTICALS LTDIntas Pharmaceuticals Ltd.
Type
Therapeutic
Approval Details
Approval Id
bb3661aaec8449cf
Drug Name
CLARYTAS 250 TABLET 250 mg
Product Name
CLARYTAS 250 TABLET 250 mg
Approval Number
SIN11742P
Approval Date
2001-12-06
Registrant
APOTHECA MARKETING PTE LTD
Licence Holder
APOTHECA MARKETING PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
J01FA09
Atc Item Name
clarithromycin
Pharma Manufacturer Name
APOTHECA MARKETING PTE LTD
Company Detail Path
/organization/apotheca-marketing-pte-ltd
Active Ingredients
Clarithromycin
250 mg
Clarithromycin
250 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 6, 2001
Approval ID
bb3661aaec8449cf
Type
Therapeutic
Back to HSA Approvals